The Federal Court of Australia ordered CDA Clinics QLD Pty Ltd, which traded as CDA Express, to pay a $6.5 million penalty over advertising of CBD products, according to a judgment published on 30 October 2026.
A peer-reviewed study in BMJ Open analysed 52,419 approved TGA applications for medicinal cannabis for Australians aged 25 or younger from 2016 to 2024, and found most were for people aged 20 to 25.
We ran the numbers..
The Sydney Morning Herald reported that a Fair Work Commission full bench rejected a University of Newcastle professor's appeal against his dismissal over consent failures in research that included a cannabinoid partnership with Ecofibre.
The Australian Commission on Safety and Quality in Health Care has published a report for clinicians summarising systematic reviews of medicinal cannabis evidence from 2020 to 2025.
The Department of Veterans' Affairs said in a 6 October statement responding to Four Corners' "Defenceless" that it has updated its Medicinal Cannabis Framework, including requiring initial GP consultations.
ECS Botanics Holdings told the ASX on 7 October 2026 it has entered a distribution and manufacturing agreement with Curaleaf Laboratories for ECS-branded medicinal cannabis in the UK.
The TGA said on 29 September it has published guidance explaining when news content about therapeutic goods may be regulated as advertising.
SBS News reported that Medicinal Organic Cannabis Australia removed a website statement about its products' approval status after the broadcaster's inquiries.
ABC News reported that a veteran was prescribed very high THC doses through DVA-funded for-profit providers, and that DVA has since tightened its rules.
Two of eleven. That's the entire bar for a diagnosis now making headlines as "cannabis addiction."
Roughly one in ten people who try cannabis goes on to develop cannabis use disorder (CUD). What separates that minority from everyone else who uses cannabis without it becoming a problem has never been well understood.